Associated Papers
Pan-cancer atlas of somatic core and linker histone mutations.
Bonner ER et al.
Npj Genomic Medicine, 2023
37640703 (PubMed )
Supplement: 41525_2023_367_MOESM2_ESM.xlsx › Supplementary_Data_File_1
High p16 expression and heterozygous RB1 loss are biomarkers for CDK4/6 inhibitor resistance in ER+ breast cancer.
Palafox M et al.
Nature Communications, 2022
36071033 (PubMed )
Supplement: 41467_2022_32828_MOESM4_ESM.xlsx › Fig_2A_and_Table_S4
Select a paper to view details